Oppenheimer analyst Suraj Kalia maintained a Buy rating on Butterfly Network (BFLY – Research Report) on January 18 and set a price target of $3.75. The company’s shares opened today at $1.06.
Kalia covers the Healthcare sector, focusing on stocks such as Edwards Lifesciences, Shockwave Medical, and Atricure. According to TipRanks, Kalia has an average return of 5.2% and a 52.16% success rate on recommended stocks.
Currently, the analyst consensus on Butterfly Network is a Strong Buy with an average price target of $3.42, representing a 222.64% upside. In a report released on January 8, TD Cowen also assigned a Buy rating to the stock with a $3.00 price target.
See today’s best-performing stocks on TipRanks >>
Based on Butterfly Network’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $15.42 million and a GAAP net loss of $27.37 million. In comparison, last year the company earned a revenue of $19.62 million and had a GAAP net loss of $54.74 million
Based on the recent corporate insider activity of 31 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of BFLY in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Butterfly Network (BFLY) Company Description:
Longview Acquisition Corp is a blank check company.
Read More on BFLY:
